Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States

Sammy Saab,S. Virabhak,H. Parisé,Scott J. Johnson,Alice Wang,D Misurski,Yuri Sanchez Gonzalez,Timothy Juday

Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States

2016

Sammy Saab
S. Virabhak
H. Parisé
Scott J. Johnson
Alice Wang
D Misurski
Yuri Sanchez Gonzalez
Timothy Juday

Introduction New treatments for chronic hepatitis C virus (HCV) are highly effective in patients coinfected with human immunodeficiency virus (HIV). This study estimated the cost-effectiveness of treatments for genotype 1 (GT1) HCV in HIV-coinfected patients.

Keywords:

Ritonavir
Immunodeficiency
Hepatitis C virus
Hepacivirus
Virus
Sofosbuvir
Ribavirin
Genotype
Virology
Medicine
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations